Capital Research Global Investors
Position in PBH — Prestige Consumer Healthcare Inc.
CIK 1422848
Los Angeles, CA
Position in PBH
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$53,027,624
+$18,388,875 QoQ
Shares Held
894,679
+59.3% QoQ
Ownership
1.89%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PBH Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Capital Research Global Investors holds $379,822,888 across 2 Drug Manufacturers - Specialty & Generic names.
All Filings in PBH
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $53,027,624 | 894,679 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $34,638,749 | 561,497 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $16,852,492 | 270,072 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $23,628,413 | 295,910 | Shares | Defined | 2025-08-13 | |
| No filing history on record for this holder in this stock. | ||||||